The CBDG lab is led by the PI, Dr. Ya Cui, with around many highly motivated graduate and undergraduate students. Our lab develops and applies innovative computational and statistical methods to address fundamental questions in biomedical sciences using large-scale genomic and biobank data.
Congratulations! Our collaboration work has been accepted by JCI (Dr. Wang, Dr. Ye and Dr. Lyu as co-first authors). In this paper, we found that a common non-coding deletion in European and South Asian populations confers a trade-off between gallstone disease and steroid sulfation capacity.
Our NIH R01 grant application on Tandem Repeat (Dr. Cui as Co-I) has been reviewed and got 7th percentile.
Congratulations! Our collaboration work has been accepted by Nature Biomedical Engineering (Dr. Cui and Dr. Ye as co-first authors). Our findings reveal APA-driven MHC-I suppression as a previously unrecognized mechanism of immune escape in immune-cold tumors and establish LNP-3'UTRCES as a versatile platform for post-transcriptional RNA engineering in cancer and other APA-associated diseases.
Our NIH RC2 grant application (Dr. Cui as Co-I) has been reviewed and got impact score 22. We have received a Just-In-Time (JIT) request from NIH.
Our NIH R01 grant application on APA (Dr. Cui as Co-I) has been reviewed and got 8th percentile. We have received a Just-In-Time (JIT) request from NIH.
Our NIH grant application on tandem repeats (Dr. Cui as PI) has selected to advance to the second round! In this highly competitive funding mechanism, only applications scoring within the 13th percentile were invited to proceed to the second round.